dc.contributorAgudelo Berruecos, Yuli
dc.contributorVallejos, Alvaro
dc.creatorSantisteban Pérez, Natalia
dc.date.accessioned2013-08-05T21:35:15Z
dc.date.available2013-08-05T21:35:15Z
dc.date.created2013-08-05T21:35:15Z
dc.date.issued2013
dc.identifierhttp://repository.urosario.edu.co/handle/10336/4514
dc.identifierhttps://doi.org/10.48713/10336_4514
dc.description.abstractIntroduction: Tuberculosis (TB) is considered a highly prevalent disease worldwide and a public health problem by the decrease in the cure rate since the appearance of multi-resistant TB and widespread, so it is necessary to design emerging management strategies to slow down the increasing incidence of TB worldwide. Methods: We performed a systematic literature research through PubMed and HINARI directing the search to studies evaluating outcomes of MDR TB management according to the goals set by last WHO guide. Results: We collected 9 articles tracking a cohort in different parts worldwide according to the inclusion criteria, in the sample collected from these 9 articles, 4720 people were treated from the beginning, 4163 (88%) of the cases were identified as MDR TB and 557 (12%) cases accounted for XDR TB. From this sample were excluded patients transferred to other institutions, leaving a total of 4455. We found that the overall cure rate exceeds 50% of the sample with individualized management however; mortality remains representative and higher compared with other variables. Conclusions: The studies evaluated multiple management strategies in different countries without conclusive results about a standardized management strategy. Elaborate a meta-analysis is not possible due to the poor characterization of the treatment schedules used in each study and poorly delineated definitions.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherToxicología Clínica
dc.publisherFacultad de Medicina
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto completo)
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombia
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma.
dc.sourcePontali E, Matteelli A, Migliori G. Drug-resistant tuberculosis. Curr Opin Pulm Med 2013; 19:266–272
dc.sourcePrasad R.M. Multidrug and Extensively Drug-Resistant TB (M/XDR-TB) Management: Current Issues. Clinical Epidemiology and Global Health. 2013. IN PRESS.
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectFallo terapéutico
dc.subjectTuberculosis drogo resistente
dc.subjectTuberculosis multiresistente
dc.subjectTuberculosis de resistencia extendida
dc.subjectTerapéutica
dc.subjectResultados del tratamiento
dc.titleDesenlaces del tratamiento de pacientes adultos con tuberculosis multiresistente y con resistencia extendida. Revisión sistemática.
dc.typemasterThesis


Este ítem pertenece a la siguiente institución